Cartesian Therapeutics (RNAC) Research & Development (2015 - 2026)
Cartesian Therapeutics' Research & Development was $20.43 million in Q2 2026, up 37.4% from $14.87 million a year earlier and up 5.0% from the prior quarter.
Powered by 
Analysis
Cartesian Therapeutics (RNAC) Research & Development (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Cartesian Therapeutics' Research & Development was $68.39 million through Jun 30, 2026, up 30.9% year-over-year; for FY2025, it was $58.03 million, up 28.7% from FY2024.
- Research & Development shows a five-year compound annual growth rate of 1.3% (FY2020 to FY2025).
- In earlier years, Research & Development was $45.11 million in FY2024 (-36.7%), $71.26 million in FY2023 (-1.5%), $72.38 million in FY2022 (+5.3%) and $68.74 million in FY2021 (+26.1%).
- The Q2 2026 figure marks the highest quarterly Research & Development since Q4 2023.
- Compared with a year earlier, Research & Development has increased for six straight quarters, with growth averaging 16.1% over the last eight quarters.
- The best year-over-year quarter for Research & Development over five years was Q1 2025 (growth of 50.7%); the worst was Q4 2024 (a decline of 48.3%).
- Per Business Quant data, RNAC's Research & Development in the three quarters before Q2 2026 was $19.46 million (Q1 2026), $14.69 million (Q4 2025) and $13.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Cartesian Therapeutics | 188.59 Mn | -346.18 Mn | - | 20.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.43 Mn |
| Mar 31, 2026 | 19.46 Mn |
| Dec 31, 2025 | 14.69 Mn |
| Sep 30, 2025 | 13.80 Mn |
| Jun 30, 2025 | 14.87 Mn |
| Mar 31, 2025 | 14.67 Mn |
| Dec 31, 2024 | 11.31 Mn |
| Sep 30, 2024 | 11.40 Mn |
| Jun 30, 2024 | 12.66 Mn |
| Mar 31, 2024 | 9.74 Mn |
| Dec 31, 2023 | 21.85 Mn |
| Sep 30, 2023 | 13.00 Mn |
| Jun 30, 2023 | 17.78 Mn |
| Mar 31, 2023 | 18.62 Mn |
| Dec 31, 2022 | 18.97 Mn |
| Sep 30, 2022 | 16.54 Mn |
| Jun 30, 2022 | 19.18 Mn |
| Mar 31, 2022 | 17.69 Mn |
| Dec 31, 2021 | 20.32 Mn |
| Sep 30, 2021 | 20.95 Mn |
API Access
Cartesian Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=RNAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "RNAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=RNAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();